EPHX2 and depressive symptom measurement: Basically, this paper focuses on the role of hepatic epoxide metabolism as an essential bridging mechanism between BC and depression, providing evidence for the pathogenesis of depression and BC comorbidity as well as clarifying the variabilities in sEH effects across BC subtypes.